US2022175638A1PendingUtilityA1
Cell activator
Est. expiryApr 5, 2039(~12.7 yrs left)· nominal 20-yr term from priority
A61K 33/42A61K 31/409A61K 38/41A61K 2800/805A61K 8/37A61K 8/25A61K 8/891A61K 8/27A61K 8/29A61K 8/8147A61K 8/602A61K 8/585A61Q 19/00A61K 8/368A61K 8/67A61K 8/022A61K 45/06A61K 33/30A61Q 19/08A61Q 17/04A61K 2800/48A61K 8/73A61K 8/673A61P 17/00A61K 8/895A61K 8/23A61K 2800/434A61K 8/44A61K 2800/614A61K 8/4926A61K 8/8158A61K 47/10A61K 9/06
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
[Problem] To provide a novel cell activator.[Solution] Provided are: a cell activator comprising a wavelength conversion substance as an active ingredient; a composition and a product comprising the cell activator; and a method for activating skin using thereof. The present invention can exhibit a desirable effect on skin by effectively making use of ultraviolet light to activate skin cells.
Claims
exact text as granted — not AI-modified1 . A cell activator comprising a wavelength conversion substance as an active ingredient,
wherein the wavelength conversion substance converts the wavelength of ultraviolet light contained in incident light to emit emission light having a wavelength longer than the wavelength of the ultraviolet light.
2 . The cell activator according to claim 1 , wherein the ultraviolet light has a peak wavelength between 200 nm and 400 nm.
3 . The cell activator according to claim 1 , wherein the emission light has a peak wavelength between 500 nm and 700 nm.
4 . The cell activator according to claim 1 , wherein the wavelength conversion substance comprises one or more phycobiliproteins selected from among allophycocyanin, C-phycocyanin, R-phycocyanin, phycoerythrocyanin, B-phycoerythrin, b-phycoerythrin, C-phycoerythrin and R-phycoerythrin; one or more inorganic phosphors selected from among zinc oxide phosphors, magnesium titanate phosphors and calcium phosphate phosphors; one or more components selected from among vitamin A, β-carotene, vitamin K, vitamin B1, vitamin B2, vitamin B6, vitamin B12, folic acid, niacin, lycopene, gardenia, safflower, turmeric, cochineal, perilla, red cabbage, flavonoids, carotenoids, quinoids, porphyrins, anthocyanins, polyphenols, salicylic acid and capsicum extract; and/or one or more pigments selected from among Red No. 401, Red No. 227, Red No. 504, Red No. 218, Orange No. 205P, Yellow No. 4, Yellow No. 5, Green No. 201, Pyranin Conch, Blue No. 1, 2,4-diaminophenoxyethanol hydrochloride, Arizulin Purple SS, Violet No. 401, Black No. 401, Helindone Pink, Yellow No. 401, Bentizine Yellow G, Blue No. 404, Red No. 104, meta-aminophenol, capsicum pigment, gardenia pigment and paprika pigment.
5 . The cell activator according to claim 4 , wherein the wavelength conversion substance comprises one or more phycobiliproteins selected from among allophycocyanin, C-phycocyanin, R-phycocyanin, phycoerythrocyanin, B-phycoerythrin, b-phycoerythrin, C-phycoerythrin and R-phycoerythrin; one or more inorganic phosphors selected from among zinc oxide phosphors, magnesium titanate phosphors and calcium phosphate phosphors; and/or one or more B vitamins selected from among vitamin B1, vitamin B2, vitamin B6 and vitamin B12.
6 . A composition comprising the cell activator according to claim 1 .
7 . The composition according to claim 6 , wherein the composition is a skin external composition for activating skin by exposing skin to light containing ultraviolet light.
8 . A cosmetic method for activating skin of a subject, comprising:
applying the composition according to claim 6 to skin of a subject, and exposing the composition-applied skin with light containing ultraviolet light.
9 . A product comprising the cell activator according to claim 1 .
10 . The product according to claim 9 , wherein the product is for activating skin by exposing the skin to light passing through the product, which contains ultraviolet light.
11 . A cosmetic method for activating skin of a subject, comprising:
bringing light containing ultraviolet light through the product according to claim 9 , and exposing the skin of the subject to light passing through the product.Join the waitlist — get patent alerts
Track US2022175638A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.